Original Research
Published on 30 Oct 2024
Sexual life in adults treated for brain tumors: a retrospective study
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1483697
- 253 views
Type at least 3 characters
29,213 articles
Articles
Original Research
Accepted on 29 Oct 2024
The combination of "HALP score" and time to castration resistance enhances the prognosis prediction in patients with castration-resistant metastatic prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1431629
Editorial
Accepted on 29 Oct 2024
Editorial: KRAS in Stage IV Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1517049
Systematic Review
Accepted on 29 Oct 2024
A Systematic Review and Meta-analysis of Clinical Prognostic Factors Linked to Extravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1475044
Original Research
Published on 29 Oct 2024
Preoperative subjective impairments in language and memory in brain tumor patients
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1475860
- 478 views
Original Research
Published on 29 Oct 2024
Factors affecting lymphedema after neoadjuvant chemotherapy and axillary dissection in female breast cancer patients: a retrospective cohort study based on the Chinese population
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1436748
- 335 views
Review
Published on 29 Oct 2024
Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1325575
- 664 views
Systematic Review
Published on 29 Oct 2024
Bibliometric and visualization analysis in the field of epigenetics and glioma (2009–2024)
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1431636
- 621 views
Original Research
Published on 29 Oct 2024
Patterns of expression of VEGFR2, PDGFRs and c-Kit in pediatric patients with high grade non-rhabdomyosarcoma soft tissue sarcoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1480773
- 390 views
Original Research
Published on 29 Oct 2024
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1376551
- 953 views
Original Research
Published on 29 Oct 2024
Evaluation of the positional reproducibility of sedation versus non-sedation state in pediatric radiotherapy: a retrospective study
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1475060
- 279 views
Case Report
Published on 29 Oct 2024
Primary hepatoid adenocarcinoma of the lung in patient with silicosis: a case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1380717
- 325 views
Review
Published on 29 Oct 2024
Treatment of brain metastases from non-small cell lung cancer: preclinical, clinical, and translational research
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1411432
- 539 views
Original Research
Published on 29 Oct 2024
The peritumoral edema index and related mechanisms influence the prognosis of GBM patients
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1417208
- 379 views
Original Research
Accepted on 28 Oct 2024
Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1435559
Original Research
Accepted on 28 Oct 2024
Initial Experience in Implementing Quantitative DCE-MRI to Predict Breast Cancer Therapy Response in a Multi-Center and Multi-Vendor Platform Setting
in Cancer Imaging and Image-directed Interventions
Frontiers in Oncology
doi 10.3389/fonc.2024.1395502
- 102 views